Close



Apr 19, 2023 05:10PM
Apr 19, 2023 05:09PM
Mar 7, 2023 04:35PM
Mar 7, 2023 04:30PM
Dec 23, 2022 04:58AM
Dec 23, 2022 01:30AM
Nov 9, 2022 01:30AM DBV Technologies to Highlight New Clinical Data at ACAAI 2022
Nov 3, 2022 04:30PM
Sep 21, 2022 06:06PM
Sep 21, 2022 05:47PM
Sep 21, 2022 05:45PM
Sep 7, 2022 04:30PM
Aug 10, 2022 04:50PM
Aug 1, 2022 04:30PM DBV Technologies Reports Second Quarter 2022 Financial Results
Jun 28, 2022 06:15PM
Jun 8, 2022 09:19AM
Jun 7, 2022 06:00PM
Jun 7, 2022 04:30PM
Jun 7, 2022 04:30PM
May 2, 2022 04:00PM
Mar 3, 2022 04:15PM DBV Technologies Reports Full Year 2021 Financial Results and Recent Business Updates
Dec 20, 2021 04:16PM
Dec 20, 2021 04:15PM
Oct 26, 2021 04:15PM
Aug 2, 2021 04:15PM
May 3, 2021 09:07AM
Mar 11, 2021 04:30PM
Feb 22, 2021 01:30AM DBV Technologies annonce la nomination de Michele F. Robertson au poste de Directrice Juridique Groupe
Jan 15, 2021 09:22AM
Jan 15, 2021 07:43AM
Jan 14, 2021 05:31PM
Jan 14, 2021 04:31PM
Jan 14, 2021 04:30PM
Nov 2, 2020 08:41AM
Nov 2, 2020 01:30AM DBV Technologies Announces Filing and Validation of Marketing Authorization Application for Viaskin™ Peanut by European Medicines Agency 
Oct 30, 2020 02:30AM
Sep 9, 2020 01:30AM
Aug 4, 2020 06:16AM
Aug 4, 2020 01:30AM
Jul 31, 2020 01:30AM
Jul 10, 2020 09:01AM
Jul 10, 2020 09:00AM DBV Technologies Announces Publication of PEOPLE Phase III Open-Label Extension Study Evaluating Viaskin Peanut in The Journal of Allergy and Clinical Immunology
Jun 26, 2020 09:16AM
Jun 26, 2020 02:30AM
Jun 4, 2020 04:30PM
Mar 17, 2020 09:23AM
Mar 17, 2020 05:22AM
Mar 16, 2020 06:10PM
Mar 16, 2020 04:32PM DBV Technologies (DBVT) announces APAC meeting to discuss BLA for Viaskin Peanut will no longer take place on May 15
Mar 16, 2020 04:30PM

251,112 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All